Zhongcong Xie, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Inhalation | 34 | 2023 | 570 | 8.550 |
Why?
|
| Isoflurane | 27 | 2023 | 380 | 6.840 |
Why?
|
| Methyl Ethers | 9 | 2017 | 205 | 3.000 |
Why?
|
| Caspase 3 | 13 | 2014 | 758 | 2.530 |
Why?
|
| tau Proteins | 10 | 2023 | 1868 | 2.220 |
Why?
|
| Amyloid beta-Peptides | 21 | 2016 | 3587 | 2.080 |
Why?
|
| Cognition Disorders | 15 | 2016 | 4043 | 1.920 |
Why?
|
| Caspases | 7 | 2014 | 928 | 1.480 |
Why?
|
| Deoxyglucose | 3 | 2016 | 337 | 1.380 |
Why?
|
| Anesthesia | 6 | 2023 | 1561 | 1.330 |
Why?
|
| Amyloid beta-Protein Precursor | 12 | 2011 | 1121 | 1.230 |
Why?
|
| Alzheimer Disease | 18 | 2023 | 8037 | 1.180 |
Why?
|
| Delirium | 10 | 2023 | 1609 | 1.160 |
Why?
|
| Anesthetics, General | 3 | 2012 | 152 | 1.080 |
Why?
|
| Propofol | 4 | 2023 | 629 | 1.050 |
Why?
|
| Antimetabolites | 2 | 2016 | 125 | 1.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 9 | 2014 | 584 | 0.900 |
Why?
|
| Apoptosis | 13 | 2013 | 9727 | 0.890 |
Why?
|
| Interleukin-6 | 8 | 2022 | 3200 | 0.840 |
Why?
|
| Enzyme Activation | 14 | 2014 | 3701 | 0.820 |
Why?
|
| Mice, Inbred C57BL | 25 | 2023 | 21827 | 0.810 |
Why?
|
| Mitochondria | 6 | 2014 | 3520 | 0.770 |
Why?
|
| Neurons | 13 | 2021 | 9338 | 0.770 |
Why?
|
| Hippocampus | 9 | 2021 | 3675 | 0.750 |
Why?
|
| Postoperative Complications | 15 | 2023 | 15295 | 0.750 |
Why?
|
| Olfaction Disorders | 1 | 2022 | 222 | 0.710 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2014 | 895 | 0.710 |
Why?
|
| Anesthetics | 3 | 2014 | 539 | 0.660 |
Why?
|
| Mice | 38 | 2023 | 81183 | 0.660 |
Why?
|
| Cytotoxins | 2 | 2016 | 153 | 0.620 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2012 | 290 | 0.590 |
Why?
|
| Learning | 5 | 2013 | 1713 | 0.590 |
Why?
|
| Memory | 5 | 2014 | 2174 | 0.590 |
Why?
|
| Mice, Transgenic | 11 | 2023 | 9734 | 0.580 |
Why?
|
| Cognition | 7 | 2023 | 6770 | 0.570 |
Why?
|
| Locomotion | 1 | 2019 | 378 | 0.570 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2014 | 297 | 0.570 |
Why?
|
| Animals | 52 | 2023 | 168757 | 0.570 |
Why?
|
| RNA Interference | 5 | 2006 | 2889 | 0.560 |
Why?
|
| Anesthesia, General | 3 | 2023 | 1171 | 0.560 |
Why?
|
| Neurofilament Proteins | 1 | 2018 | 318 | 0.550 |
Why?
|
| Blotting, Western | 12 | 2014 | 5179 | 0.540 |
Why?
|
| Protein Transport | 2 | 2021 | 1988 | 0.530 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2014 | 430 | 0.520 |
Why?
|
| Cytoprotection | 2 | 2014 | 210 | 0.500 |
Why?
|
| Hippocalcin | 1 | 2014 | 8 | 0.500 |
Why?
|
| Animals, Newborn | 5 | 2021 | 2726 | 0.500 |
Why?
|
| Synapses | 2 | 2013 | 1728 | 0.470 |
Why?
|
| Cell Line, Tumor | 19 | 2016 | 16689 | 0.470 |
Why?
|
| Gene Silencing | 3 | 2005 | 1538 | 0.470 |
Why?
|
| Aspartic Acid Endopeptidases | 3 | 2011 | 311 | 0.470 |
Why?
|
| Brain | 12 | 2021 | 26385 | 0.460 |
Why?
|
| Membrane Proteins | 5 | 2014 | 7880 | 0.460 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1889 | 0.460 |
Why?
|
| Prenatal Injuries | 1 | 2013 | 13 | 0.460 |
Why?
|
| Maze Learning | 5 | 2017 | 478 | 0.450 |
Why?
|
| Ubiquitination | 1 | 2017 | 1012 | 0.440 |
Why?
|
| Nerve Tissue Proteins | 5 | 2013 | 4462 | 0.440 |
Why?
|
| Nootropic Agents | 1 | 2014 | 160 | 0.430 |
Why?
|
| Signal Transduction | 6 | 2021 | 23403 | 0.430 |
Why?
|
| Phosphorylation | 6 | 2023 | 8436 | 0.400 |
Why?
|
| Inflammation | 4 | 2021 | 10638 | 0.400 |
Why?
|
| Nitrous Oxide | 2 | 2009 | 177 | 0.400 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 10 | 2021 | 3870 | 0.390 |
Why?
|
| Peptide Fragments | 3 | 2013 | 5097 | 0.390 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 1338 | 0.390 |
Why?
|
| Ascorbic Acid | 1 | 2014 | 651 | 0.390 |
Why?
|
| Preoperative Period | 1 | 2013 | 549 | 0.390 |
Why?
|
| Glioma | 5 | 2014 | 3401 | 0.380 |
Why?
|
| Testosterone | 1 | 2021 | 2420 | 0.380 |
Why?
|
| Pain | 3 | 2017 | 4986 | 0.380 |
Why?
|
| Neuroprotective Agents | 2 | 2014 | 941 | 0.370 |
Why?
|
| Random Allocation | 5 | 2017 | 2429 | 0.370 |
Why?
|
| Hemoglobins | 1 | 2016 | 1534 | 0.360 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2023 | 954 | 0.350 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.350 |
Why?
|
| Encephalitis | 1 | 2013 | 423 | 0.340 |
Why?
|
| Disease Models, Animal | 11 | 2021 | 18029 | 0.340 |
Why?
|
| Neural Stem Cells | 2 | 2013 | 851 | 0.340 |
Why?
|
| Endocytosis | 1 | 2013 | 985 | 0.320 |
Why?
|
| Cytosol | 2 | 2009 | 901 | 0.320 |
Why?
|
| Anesthetics, Intravenous | 1 | 2011 | 417 | 0.320 |
Why?
|
| Reactive Oxygen Species | 5 | 2014 | 2077 | 0.320 |
Why?
|
| Age Factors | 7 | 2020 | 18370 | 0.310 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1162 | 0.310 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1114 | 0.300 |
Why?
|
| Memantine | 1 | 2008 | 100 | 0.300 |
Why?
|
| Neurogenesis | 1 | 2013 | 838 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2010 | 1990 | 0.260 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 972 | 0.260 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2011 | 643 | 0.250 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2006 | 382 | 0.250 |
Why?
|
| C-Reactive Protein | 4 | 2021 | 3778 | 0.240 |
Why?
|
| Hypocapnia | 1 | 2004 | 34 | 0.240 |
Why?
|
| Adenosine Triphosphate | 3 | 2015 | 2025 | 0.240 |
Why?
|
| Endopeptidases | 2 | 2005 | 772 | 0.240 |
Why?
|
| Transfection | 4 | 2006 | 5892 | 0.230 |
Why?
|
| Humans | 61 | 2023 | 744343 | 0.230 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 1622 | 0.230 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2013 | 2408 | 0.220 |
Why?
|
| Bacteroidetes | 1 | 2023 | 83 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2014 | 4420 | 0.220 |
Why?
|
| Glucose | 1 | 2014 | 4397 | 0.210 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2013 | 1462 | 0.210 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1876 | 0.210 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2013 | 1458 | 0.210 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 2 | 2014 | 154 | 0.200 |
Why?
|
| Aging | 5 | 2014 | 8664 | 0.200 |
Why?
|
| Cell Hypoxia | 3 | 2011 | 675 | 0.190 |
Why?
|
| Neuropeptides | 1 | 2006 | 942 | 0.190 |
Why?
|
| Pain Threshold | 2 | 2014 | 584 | 0.180 |
Why?
|
| Male | 27 | 2023 | 350118 | 0.180 |
Why?
|
| Serine | 1 | 2023 | 826 | 0.170 |
Why?
|
| Calcium | 2 | 2014 | 5756 | 0.170 |
Why?
|
| Proteomics | 3 | 2023 | 3638 | 0.170 |
Why?
|
| Dexmedetomidine | 1 | 2023 | 315 | 0.160 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 5708 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2006 | 2916 | 0.160 |
Why?
|
| Female | 28 | 2023 | 380194 | 0.160 |
Why?
|
| Perioperative Period | 1 | 2020 | 256 | 0.160 |
Why?
|
| Aged | 18 | 2023 | 163280 | 0.160 |
Why?
|
| Carrier Proteins | 3 | 2007 | 5021 | 0.160 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 1912 | 0.150 |
Why?
|
| Tauopathies | 1 | 2021 | 307 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 365 | 0.150 |
Why?
|
| Carbamates | 2 | 2009 | 196 | 0.150 |
Why?
|
| Fear | 3 | 2014 | 1440 | 0.150 |
Why?
|
| Psychomotor Agitation | 1 | 2019 | 293 | 0.140 |
Why?
|
| Drug Synergism | 2 | 2015 | 1792 | 0.140 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 3768 | 0.140 |
Why?
|
| RNA, Small Interfering | 5 | 2006 | 3505 | 0.140 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 6993 | 0.140 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 4262 | 0.140 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2018 | 245 | 0.140 |
Why?
|
| Dipeptides | 2 | 2009 | 409 | 0.140 |
Why?
|
| Presenilin-1 | 3 | 2005 | 635 | 0.140 |
Why?
|
| Sleep | 1 | 2012 | 4623 | 0.140 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6622 | 0.140 |
Why?
|
| Ubiquinone | 2 | 2015 | 188 | 0.140 |
Why?
|
| Cell Survival | 3 | 2014 | 5882 | 0.130 |
Why?
|
| Cells, Cultured | 7 | 2017 | 19229 | 0.130 |
Why?
|
| Nitro Compounds | 1 | 2015 | 74 | 0.130 |
Why?
|
| Lipids | 1 | 2006 | 3305 | 0.130 |
Why?
|
| Escape Reaction | 1 | 2014 | 54 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1017 | 0.120 |
Why?
|
| Behavior, Animal | 2 | 2014 | 1881 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14557 | 0.120 |
Why?
|
| Freund's Adjuvant | 1 | 2014 | 139 | 0.120 |
Why?
|
| Species Specificity | 2 | 2010 | 2478 | 0.120 |
Why?
|
| Propionates | 1 | 2015 | 169 | 0.120 |
Why?
|
| Proteome | 2 | 2022 | 1799 | 0.120 |
Why?
|
| Prospective Studies | 9 | 2023 | 53288 | 0.120 |
Why?
|
| Flumazenil | 1 | 2014 | 84 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1438 | 0.120 |
Why?
|
| GABA Antagonists | 1 | 2014 | 128 | 0.120 |
Why?
|
| Carnitine | 1 | 2015 | 246 | 0.120 |
Why?
|
| GABA Agonists | 1 | 2014 | 111 | 0.110 |
Why?
|
| Neuregulin-1 | 1 | 2014 | 142 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 6314 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2013 | 112 | 0.110 |
Why?
|
| Hyperalgesia | 1 | 2017 | 502 | 0.110 |
Why?
|
| Amyloidogenic Proteins | 1 | 2014 | 152 | 0.110 |
Why?
|
| Physician Executives | 1 | 2014 | 128 | 0.110 |
Why?
|
| Microglia | 1 | 2021 | 1266 | 0.110 |
Why?
|
| Ibuprofen | 1 | 2014 | 236 | 0.110 |
Why?
|
| Dementia | 1 | 2006 | 2518 | 0.110 |
Why?
|
| Eating | 1 | 2019 | 1536 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 3846 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 5853 | 0.100 |
Why?
|
| Peptide Hydrolases | 2 | 2005 | 634 | 0.100 |
Why?
|
| Lithium | 1 | 2014 | 601 | 0.100 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 11366 | 0.100 |
Why?
|
| Accreditation | 1 | 2014 | 450 | 0.090 |
Why?
|
| China | 2 | 2019 | 2248 | 0.090 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 366 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2010 | 4217 | 0.090 |
Why?
|
| Anesthesiology | 2 | 2014 | 1060 | 0.090 |
Why?
|
| Nanotechnology | 1 | 2016 | 710 | 0.090 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 884 | 0.090 |
Why?
|
| Body Weight | 2 | 2019 | 4669 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 2418 | 0.090 |
Why?
|
| Caspase 9 | 1 | 2009 | 188 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2013 | 721 | 0.090 |
Why?
|
| Cytochromes c | 1 | 2009 | 180 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 10943 | 0.080 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 391 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 1213 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 1372 | 0.080 |
Why?
|
| Anesthesia, Spinal | 1 | 2011 | 269 | 0.080 |
Why?
|
| Clioquinol | 1 | 2008 | 23 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2009 | 295 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 3798 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 1059 | 0.080 |
Why?
|
| Neuroblastoma | 1 | 2016 | 1226 | 0.080 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 1105 | 0.080 |
Why?
|
| Abdomen | 1 | 2014 | 1118 | 0.080 |
Why?
|
| Presenilins | 1 | 2007 | 54 | 0.070 |
Why?
|
| Cell Line | 2 | 2012 | 15997 | 0.070 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2006 | 46 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2016 | 2250 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2022 | 3537 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 436 | 0.070 |
Why?
|
| Antioxidants | 1 | 2015 | 1663 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2011 | 970 | 0.070 |
Why?
|
| Vitamins | 1 | 2015 | 1622 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1970 | 0.070 |
Why?
|
| Mutation | 3 | 2005 | 29786 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1856 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2023 | 8301 | 0.070 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 3462 | 0.060 |
Why?
|
| Plaque, Amyloid | 1 | 2009 | 729 | 0.060 |
Why?
|
| Time Factors | 3 | 2014 | 40075 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.060 |
Why?
|
| Hypercapnia | 1 | 2006 | 260 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 1121 | 0.060 |
Why?
|
| Risk Factors | 6 | 2023 | 72290 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2014 | 3002 | 0.060 |
Why?
|
| Cytokines | 1 | 2019 | 7322 | 0.060 |
Why?
|
| Research Design | 1 | 2020 | 5987 | 0.060 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 666 | 0.060 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2023 | 69 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2899 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2006 | 739 | 0.060 |
Why?
|
| Protein Binding | 2 | 2006 | 9386 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2006 | 675 | 0.060 |
Why?
|
| Electroporation | 1 | 2005 | 251 | 0.060 |
Why?
|
| Rats | 6 | 2023 | 24260 | 0.060 |
Why?
|
| Linear Models | 1 | 2013 | 5952 | 0.060 |
Why?
|
| Wound Healing | 1 | 2014 | 2785 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 2005 | 275 | 0.050 |
Why?
|
| Boston | 2 | 2016 | 9313 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6365 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1434 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6489 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2007 | 705 | 0.050 |
Why?
|
| Gases | 1 | 2023 | 197 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2008 | 1189 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 936 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2699 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2006 | 1150 | 0.050 |
Why?
|
| Lidocaine | 1 | 2005 | 544 | 0.050 |
Why?
|
| Exons | 2 | 2006 | 2437 | 0.050 |
Why?
|
| Actins | 1 | 2009 | 2121 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 17446 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 57776 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2291 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5974 | 0.050 |
Why?
|
| Neuroglia | 1 | 2006 | 927 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 1736 | 0.050 |
Why?
|
| Oxygen | 1 | 2012 | 4189 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2023 | 21746 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2023 | 572 | 0.050 |
Why?
|
| Indoles | 2 | 2023 | 1839 | 0.050 |
Why?
|
| Cadherins | 1 | 2005 | 907 | 0.050 |
Why?
|
| Child Development | 1 | 2012 | 2223 | 0.050 |
Why?
|
| Drosophila | 1 | 2007 | 1491 | 0.040 |
Why?
|
| Pneumonectomy | 1 | 2006 | 1094 | 0.040 |
Why?
|
| Disease Progression | 2 | 2019 | 13284 | 0.040 |
Why?
|
| Age of Onset | 1 | 2006 | 3271 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2557 | 0.040 |
Why?
|
| Progesterone | 1 | 2023 | 776 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8324 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2007 | 1076 | 0.040 |
Why?
|
| Parkinson Disease | 1 | 2012 | 2775 | 0.040 |
Why?
|
| Triglycerides | 1 | 2006 | 2454 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2005 | 985 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2007 | 1703 | 0.040 |
Why?
|
| Leadership | 1 | 2007 | 1357 | 0.040 |
Why?
|
| Pregnancy | 3 | 2013 | 29144 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2004 | 2751 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 408 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 668 | 0.030 |
Why?
|
| Estradiol | 1 | 2023 | 2020 | 0.030 |
Why?
|
| General Surgery | 1 | 2007 | 1636 | 0.030 |
Why?
|
| Middle Aged | 4 | 2013 | 213383 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 2014 | 230 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13695 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2014 | 5788 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2014 | 245 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 270 | 0.030 |
Why?
|
| Parvalbumins | 1 | 2014 | 250 | 0.030 |
Why?
|
| Motor Activity | 2 | 2014 | 2714 | 0.030 |
Why?
|
| Deoxyuridine | 1 | 2011 | 33 | 0.030 |
Why?
|
| Propidium | 1 | 2011 | 41 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2012 | 25625 | 0.020 |
Why?
|
| Models, Biological | 1 | 2008 | 9583 | 0.020 |
Why?
|
| Prevalence | 2 | 2019 | 15226 | 0.020 |
Why?
|
| Orthopedic Procedures | 1 | 2021 | 1288 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 269 | 0.020 |
Why?
|
| Staurosporine | 1 | 2011 | 251 | 0.020 |
Why?
|
| Efficiency | 1 | 2014 | 462 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 424 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 9438 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2011 | 284 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2505 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 35136 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3508 | 0.020 |
Why?
|
| Interneurons | 1 | 2014 | 577 | 0.020 |
Why?
|
| Culture Media | 1 | 2011 | 908 | 0.020 |
Why?
|
| Carcinogens | 1 | 2011 | 466 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 41006 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2011 | 566 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6933 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 497 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 816 | 0.020 |
Why?
|
| Lung | 1 | 2006 | 9856 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6309 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39050 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2017 | 3420 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 2255 | 0.020 |
Why?
|
| Haplorhini | 1 | 2007 | 552 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 40561 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8663 | 0.020 |
Why?
|
| Biotinylation | 1 | 2006 | 179 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5078 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 2472 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1706 | 0.020 |
Why?
|
| Absorption | 1 | 2005 | 248 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 56430 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 862 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 12951 | 0.020 |
Why?
|
| Adult | 2 | 2012 | 214055 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 63114 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 10388 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1564 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 8863 | 0.020 |
Why?
|
| Incidence | 1 | 2023 | 20947 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 401 | 0.010 |
Why?
|
| Thigh | 1 | 2005 | 247 | 0.010 |
Why?
|
| Child | 1 | 2012 | 77709 | 0.010 |
Why?
|
| Lipectomy | 1 | 2005 | 118 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 85781 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 780 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13989 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2759 | 0.010 |
Why?
|
| Body Patterning | 1 | 2007 | 626 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 1901 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 1549 | 0.010 |
Why?
|
| Epinephrine | 1 | 2005 | 792 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2005 | 642 | 0.010 |
Why?
|
| Neck | 1 | 2005 | 697 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15076 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2005 | 2029 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3920 | 0.010 |
Why?
|
| Retina | 1 | 2007 | 2616 | 0.010 |
Why?
|
| Anxiety | 1 | 2011 | 4297 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2006 | 4161 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10481 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25043 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2011 | 8554 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 8949 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 18111 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 77449 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 12072 | 0.000 |
Why?
|
| United States | 1 | 2007 | 69872 | 0.000 |
Why?
|